Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I and Enrichment Study of Low-dose Metronomic Topotecan and Pazopanib in Pediatric Patients With Recurrent or Refractory Solid Tumours

NCT02303028 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02303028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I and Enrichment Study of Low-dose Metronomic Topotecan and Pazopanib in Pediatric Patients With Recurrent or Refractory Solid Tumours
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2015
Completion date
June 17, 2022
Enrollment
30 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors